REMINDER: Our user survey closes on Friday, please submit your responses here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think the next update will be about the lab move.
back to 100p tomorrow
I am reliably informed (usual sources, friend of his Lordship at McDs) that a certain bearded, Northern gentleman has signed off a PO for not one, not two but three new Shumpers.
I'm getting a Stateside vibe. US market potentially taking first priority in both therapeutics and diagnostics? Quiet Al still playing a blinder methinks.
Very interesting
1. Three days of roadshow. So multiple opportunities to be asked questions - guessing confident have good (possibly great) answers ready. Wonder whether he will cover which cohort in progress - said would update on second but we have passed the timing on that.
2. The RNS today was expected news - fund raise was to ensure at least one new Tx project. Therefore timing before trading update is deliberate. Any valuation of ava6000 gets multiplied by second project.
3. What does "benefits from near term revenues" actually mean?
My guess is news will increase SP and Avacta will then move to joint listing on Nasdaq. To be done once data available on Ava6000 - they have enough cash on hand.
AgentB - The Covid opportunity, even at it's height was nowhere near the size of the current oncology market opportunity for Avacta (Circa $56Bn annually to which it has been floated Avacta could target 10% of that).
The 56Bn is currently limited due to the toxicity of those chemo drugs - so reduce toxicity and that market increases significantly! Sadly, cancer will never move to an "endemic status" that we "learn to live with"
So - at no point was C19 testing the long term value driver for the business. It was (and still is IMO) a valuable revenue generator to fund the true value driver, minimizing any cash calls to the market.
He is simply refocusing investors back to where it should be...and nicely times really as hopefully the LFT pitchfrok herd have now moved on and a new solid, long term investor base can reform.
Or perhaps he’s refining the test to exploit the covid opportunity, hence the last RNS.
AL has been indicating that we should view Precision rather than AddiDX as the main value driver for some time now. Perhaps he has also given up on the Covid opportunity.
For me (and something the market has so far today largely missed, not that I am surprised) is this sentence in the RNS:
"It represents a major commercial opportunity and the principal value driver for the Group."
Now, why would Alastair even bother to include this sentence? He certainly didn't have to.
What he has done is purposefully and I say deliberately re-focused Investor attention (and indeed the pressure) back onto the Precision platform. In this sentence he is telling Investors that the main/key value driver to the entire Group is the Precision platform.
Well, if he was about to release an RNS (soon) saying the Precision platform through AVA6000 has not worked positively in human, he certainly wouldn't be adding more focus/pressure to the situation now would he!!
Agreed - when you look at the historical timing of the trading update RNS's it was:
18Jan 2018
21Jan 2019
23 Jan 2020
24 Feb 2021
So they have no issues pushing it out a little if necessary...would be nice to see AVA6000 first read outs before that (or included in it)
Yeah he has to inform the wider market first, so an rns on Monday 31st latest!?
Update on AVA6K in the next fortnight anyone? Can’t see Al doing a Roadshow over 3 days beginning February 1st without one. Great buying opp for anyone with spare cash available
Be good to see where the land lies....
https://twitter.com/79Jadds/status/1483419377307373570